Gerard Scimeca – Chairman, CASE August 23, 2018 – https://bit.ly/2PsO20V Airline travelers often enjoy riding high in the sky, but […]
Matthew Kandrach – President, CASE August 21, 2018 – https://bit.ly/2w0o0dl Despite the current energy boom in America, gasoline prices are on […]
We all know it can get pretty cold in Canada, but things have been heating up lately as our neighbors […]
In an era where the discussion of fake news is ever present, it is painfully ironic that the left has […]
2018 has been a watershed year for the effort to reform our nation’s healthcare system and bring down the cost […]
MATTHEW KANDRACH – PRESIDENT, CASE August 7, 2018 – https://bit.ly/2vKwq7K As the dust settles from the final going-out-of-business sales and the […]
MATTHEW KANDRACH – PRESIDENT, CASE August 2, 2018 – https://bit.ly/2vreqig When the first cars were put up for sale, the […]
Last week, U.S. Department of Health and Human Services Secretary Alex Azar spoke at The Heritage Foundation about the importance […]
GERARD SCIMECA – CHAIRMAN, CASE July 27, 2018 Protection of Indiana’s coal sector and the more than 41,000 local jobs […]
Sen. Richard Durbin (D-IL) introduced an amendment to an appropriations bill this week that would force drug manufacturers to disclose […]
.@POTUS’ IRA is driving up Part D premiums for millions of Medicare beneficiaries, yet Dems like @SenSanders continue to help tout this disastrous legislation. The Biden-Harris @WhiteHouse is misleading the public on their policy’s real impact.
Two weeks from election day, the supposedly independent @FCC is proposing price regulation of #broadband by restricting what data plans companies can offer.
By prohibiting usage-based plans, the FCC would end up increasing prices FOR EVERYONE, including low-data users!
CASE Letter Urges FDA & FTC to Scrutinize Deal Between L’Oréal and Galderma -- "Both companies are currently under investigation or facing sizable lawsuits from claims that they have used harmful chemicals in their products."
https://caseforconsumers.org/2024/10/21/case-letter-urges-fda-ftc-to-scrutinize-deal-between-loreal-and-galderma/